Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Breast Cancer (Dove Medical Press)|January 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer TreatmentsLorenzo Belluzzi, Giulio Martinelli, Bianca Medici, et al.Cancer Biology & Therapy|August 2, 2018
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patientsClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.Oncotarget|September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applicationsAngela Toss, Federico Piacentini, Laura Cortesi, et al.Journal of Cancer Research and Clinical Oncology|January 4, 2019
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor statusClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.Cancer Management and Research|February 4, 2020
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant ChemotherapyClaudia Omarini, Patrizia Palumbo, Annarita Pecchi, et al.Biomed Research International|August 25, 2018
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus EverolimusClaudia Omarini, Maria Elisabetta Filieri, Stefania Bettelli, et al.International Journal of Molecular Sciences|March 13, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer PatientsFabio Canino, Antonio Tornincasa, Stefania Bettelli, et al.Frontiers in Oncology|December 19, 2022
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapyAngela Toss, Marta Venturelli, Monica Civallero, et al.Breast Cancer Research : BCR|June 23, 2018
Immune characterization of breast cancer metastases: prognostic implicationsMaria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, et al.Biomarker Research|January 24, 2025
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypesClaudia Omarini, Virginia Catani, Ilenia Mastrolia, et al.Pageof 4